IRIS
OREFICE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.376
EU - Europa 747
AS - Asia 649
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.324
IT - Italia 315
SG - Singapore 240
CN - Cina 212
HK - Hong Kong 160
NL - Olanda 112
FI - Finlandia 93
IE - Irlanda 66
DE - Germania 62
CA - Canada 51
UA - Ucraina 27
GB - Regno Unito 24
CI - Costa d'Avorio 21
SE - Svezia 14
IN - India 12
VN - Vietnam 12
RU - Federazione Russa 9
BE - Belgio 7
FR - Francia 5
LT - Lituania 5
IR - Iran 4
KR - Corea 4
MK - Macedonia 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
MX - Messico 1
NO - Norvegia 1
UY - Uruguay 1
Totale 2.795
Salva come PNG Salva come JPEG
Città #
Chandler 209
Singapore 197
Hong Kong 160
Amsterdam 106
Santa Clara 99
Naples 92
Ashburn 86
Princeton 81
Millbury 75
Beijing 62
Nanjing 57
Ottawa 42
Boston 36
Jacksonville 33
Wilmington 32
Napoli 30
Des Moines 27
Norwalk 23
Seattle 21
Nanchang 17
Helsinki 16
Hebei 14
Dong Ket 12
Jiaxing 12
Columbus 10
Shenyang 10
Augusta 9
Milan 9
Tianjin 9
Rome 8
Brussels 7
Houston 7
Toronto 7
Pune 6
Redwood City 6
Boardman 5
Guangzhou 5
Munich 5
San Mateo 5
Sant'arpino 5
Woodbridge 5
Dublin 4
Falls Church 4
Indiana 4
London 4
Los Angeles 4
Avezzano 3
Bari 3
Catania 3
Dallas 3
Falkenstein 3
Florence 3
Lanzhou 3
Leawood 3
Marigliano 3
Palermo 3
Sessa Aurunca 3
Taranto 3
Washington 3
Ardabil 2
Caserta 2
Castellammare Di Stabia 2
Changsha 2
Cologne 2
Dalmine 2
Dearborn 2
Frankfurt am Main 2
Kronberg 2
Paternò 2
Positano 2
Redmond 2
Salerno 2
Toulouse 2
Trieste 2
Walnut 2
Altamura 1
Ankara 1
Ann Arbor 1
Barrie 1
Bologna 1
Brescia 1
Brno 1
Cardito 1
Centro 1
Changchun 1
Clifton 1
Como 1
Corsano 1
Crotone 1
Cumming 1
Dundas 1
Düsseldorf 1
Edison 1
Fremont 1
Gragnano 1
Innsbruck 1
Inzago 1
Islington 1
Krimpen Aan Den Ijssel 1
Kunming 1
Totale 1.773
Salva come PNG Salva come JPEG
Nome #
Nuove tecniche di imaging nello studio delle alterazioni perfusionali cerebrali e dei processi di degenerazione neuronale in soggetti affetti da sclerosi multipla e da altre patologie neurologiche degenerative. Associazioni tra marcatori radiologici e polimorfismi genetici di predisposizione e decorso delle malattie neurodegenerative 98
The effects of mechanical focal vibration on walking impairment in multiple sclerosis patients: A randomized, double-blinded vs placebo study 71
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 62
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 61
Brain atrophy and lesion load in a large population of patients with multiple sclerosis 57
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 56
Anatomical and functional retinal changes in multiple sclerosis 55
Aerodynamic findings and Voice Handicap Index in Parkinson’s disease 55
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. 52
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 52
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 51
Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction 49
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. NeuroImage18: 360-366, 2003.. 48
Multiple sclerosis and headache co-morbidity. A case-control study 47
Epileptic seizures in multiple sclerosis: clinical and EEG correlations. 47
Communication in Multiple Sclerosis: Pragmatic Deficit and its Relation with Cognition and Social Cognition 47
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. 45
Age-related risk factors for ischemic stroke in Italian men. 45
Inhibition of oligodendrocyte differentiation by immunoglobulin purified from serum of multiple sclerosis patients during relapse 45
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis 45
Analisi conoscitiva del grado di aderenza di strutture di riabilitazione alle principali linee guida nazionali nel trattamento di pazienti afasici e disfagici. 44
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells 44
Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: Results of a randomized controlled trial 44
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 43
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis 42
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®) 41
An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results. 41
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. 39
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 39
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region 39
Switching disease-modifying therapies in multiple sclerosis: follow-up of 108 patients. In MULTIPLE SCLEROSIS (Vol. 11, pp. S159-S159). 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND: HODDER ARNOLD, HODDER HEADLINE PLC. 39
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. 37
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. 37
Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. 36
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 36
Vitamin D in a population of Southern Italy relapsing remitting and secondary progressive multiple sclerosis patients. 35
Recurrent pulmonary and cerebral thromboembolism in an adult patients following incomplete removal of ventriculoatrial shunt for congenital hydrocephalus. 35
Prognostic value of combined target-organ damage in patients with essential hypertension 35
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis 34
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. 34
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 34
Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study). 34
Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. 33
Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs. 32
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. 32
B-thromboglobulin and Platelet Factor-4 Measured By A Radioimmunoassay As Indexes of Platelet Activation In Patients With Migraine 32
Benign intracranial hypertension of obese women. A twenty cases report. 32
Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension 31
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients 30
Clinical and computerized tomographic study of a case of Schilder's disease. 29
Three primitive reflexes in HIV-1-infected individuals: a possible clinical marker of early central nervous system involvement. 29
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 29
Gender differences in non-motor symptoms in early, drug naive Parkinson's disease 28
Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis 28
Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis 27
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy. 27
Antithrombotic effect of indobufen in an experimental model of arterio-arterial microanastomosis in the rat. 27
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 27
Regional GM loss in MS: a comparison between Primary-Progressive and Relapsing-Remitting MS phenotypes. 26
Successful treatment of paraneoplastic cerebellar degeneration with Rituximab. 26
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 26
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 26
[The physiopathology of supranuclear structures in oculomotor disorders]. 26
NAbs effect on cognitive, clinical and quantitative MRI outcome measures in RR-MS IFN beta-1b treated patients 26
No effect of acetylsalicylic acid on B-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. 25
Spontaneous resolution of Chiari type 1 malformation. A case report and literature review 25
Dati aerodinamici della voce dei soggetti con malattia di Parkinson preliminari al trattamento riabilitativo logopedico 25
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinject on over a 1-year period: the CoSa study. 24
Do gonadotropins play a role in catamenial epilepsy? | [Le gonadotropine ipofisarie hanno un ruolo nella patogenesi delle crisi catameniali?]. 24
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. 23
Idiopathic intracranial hypertension in a patient with thyroid papillary carcinoma 23
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 22
[Fahr syndrome with and without hypoparathyroidism. 2 cases]. 21
Platelet-function In Childhood Migraine 20
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis. 19
Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. 19
Epilepsy and multiple sclerosis: Review of literature and our epilepsy center's experience 19
Natalizumab vs interferon beta 1a inrelapsing-remitting multiple sclerosis: a head-to-head retrospective study. 17
Usefulness of the Radioimmunoassay of B-thromboglobulin In Transient Ischemic Attacks 16
Presence of papova-like viral particles in cerebrospinal fluid of AIDS patients with progressive multifocal leukoencephalopathy. An additional test for "in vivo" diagnosis. 16
Subcutaneous interferon ?-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 16
Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study 16
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study. 14
Totale 2.943
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 0 0 0 0 0 0 3 8 3 28 53 18
2020/2021153 18 5 7 10 9 13 7 1 20 1 46 16
2021/2022418 5 0 0 2 1 18 1 16 69 49 89 168
2022/2023548 84 38 18 25 73 45 0 40 76 106 26 17
2023/2024488 15 71 120 37 32 47 10 44 5 7 76 24
2024/2025619 119 84 8 29 74 120 185 0 0 0 0 0
Totale 2.943